Skip to main content
SpringerLink
Log in

Intranasal Drug Delivery

Potential Advantages and Limitations from a Clinical Pharmacokinetic Perspective

  • Leading Article
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Alberetto M, Pontiroli AE, Calderara A, Pajetta E, Pozza G. Intranasal glucagon for hypoglycaemic crises in patients with type 1 diabetes. Abstract no. 463. Diabetologia 31: 463A, 1988

    Google Scholar 

  • Albertson-Wikland K, Westphal O, Westgren U. Daily subcutaneous administration of growth hormone in growth hormone deficient children. Acta Paediatrica Scandinavica 75: 89–97, 1986

    Article  Google Scholar 

  • Alford FP, Bloom SR, Nabarro DN. Glucagon metabolism in man. Studies on the metabolic clearance rate and the plasma acute disappearance time of glucagon in normal and diabetic subjects. Journal of Clinical Endocrinology and Metabolism 42: 830–838, 1976

    Article  PubMed  CAS  Google Scholar 

  • Aungst BJ, Rogers NG, Shefter E. Comparison of nasal, rectal, buccal, sublingual and intramuscular insulin efficacy and the effects of bile salt absorption promoter. Journal of Pharmacology and Experimental Therapeutics 244: 23–27, 1988

    PubMed  CAS  Google Scholar 

  • Borkenstein M. The effects of intranasal insufflation of growth hormone releasing factor analog GRF 1-29NH2 on growth hormone secretion in children with short stature. Acta Endocrinologica 279 (Suppl.): 135–138, 1986

    CAS  Google Scholar 

  • Buclin T, Randin JP, Jacquet AF, Azria M, Attinger M, et al. The effect of rectal and nasal administration of salmon calcitonin in normal subjects, Calcified Tissue International 41: 252–258, 1987

    Article  PubMed  CAS  Google Scholar 

  • Crozier IG, Nicholls MG, Ikram H, Espiner EA, Yandle TG. Plasma immunoreactive atrial natriuretic peptide levels after subcutaneous α-hANP injection in normal humans. Journal of Cardiovascular Pharmacology 10: 72–75, 19877

  • DeBold CR, Sheldon WR, DeCherney GS, Jackson RV, Nicholson WE, et al. Effect of subcutaneous and intranasal administration of ovine corticotropin-releasing hormone in man: comparison with intravenous administration. Journal of Clinical Endocrinology and Metabolism 60: 836–840, 1985

    Article  PubMed  CAS  Google Scholar 

  • Duchateau GSMJE, Zuidema J, Merkus FWHM. Bile salts and intranasal drug absorption. International Journal of Pharmaceutics 31: 193–199, 1986

    Article  CAS  Google Scholar 

  • Evans WS, Vance ML, Kaiser DL, Sellers RP, Borges JLC, et al. Effects of intravenous, subcutaneous, and intranasal administration of growth hormone (GH)-releasing hormone-40 on serum GH concentrations in normal men. Journal of Clinical Endocrinology and Metabolism 61: 846–850, 1985

    Article  PubMed  CAS  Google Scholar 

  • Freychet L, Rizkalla SW, Desplanque N, Basdevant A, Zirinis P, et al. Effect of intranasal glucagon on blood glucose levels in healthy subjects and hypoglycaemic patients with insulin-depedent diabetes. Lancet 1: 1364–1366, 1988

    Article  PubMed  CAS  Google Scholar 

  • Gordon GS, Moses AC, Silver RD, Flier JS, Carey MC. Nasal absorption of insulin: enhancement by hydrophobic bile salts. Proceedings of the National Academy of the Sciences of the United States of America 82: 7419–7423, 1985

    Article  CAS  Google Scholar 

  • Hanson M, Gazdick G, Cahill J, Augustine M. Intranasal delivery of the peptide, salmon calcitonin. In Davis et al. (Eds) Delivery systems for peptide drugs, pp. 233–242, Plenum Press, New York, 1986

    Google Scholar 

  • Hardy JC, Lee SW, Wilson CG. Intranasal drug delivery by spray and drops. Journal of Pharmacy and Pharmacology 37: 294–297, 1985

    Article  PubMed  CAS  Google Scholar 

  • Harris AS. Biopharmaceutical aspects of intranasal administration of peptides. In Davis et al. (Eds) Delivery systems for peptide drugs, pp. 191–204, Plenum Press, New York, 1986

    Google Scholar 

  • Hayden FG, Kaiser DL, Albrecht JK. Intranasal recombinant alpha-2b interferon treatment of naturally occurring common colds. Antimicrobial Agents and Chemotherapy 32: 225–230, 1988

    Article  Google Scholar 

  • Hermens AJJ, Merkus WHM. The influence of drugs on nasal ciliary movement. Pharmaceutical Research 4: 445–449, 1987

    Article  PubMed  CAS  Google Scholar 

  • Hersey SJ, Jackson RT. Effect of bile salts on nasal permeability in vitro. Journal of Pharmaceutical Sciences 76: 876–879, 1987

    PubMed  CAS  Google Scholar 

  • Hirai S, Ikenaga T, Matsuzawa T. Nasal absorption of insulin in dogs. Diabetes 27: 296–299, 1977

    Article  Google Scholar 

  • Hirai S, Yashiki T, Mima H. Effect of surfactants on the nasal absorption of insulin in rats. International Journal of Pharmaceutics 9: 165–172, 1981

    Article  CAS  Google Scholar 

  • Hussain AA, Foster T, Hirai S, Kashihara T, Batenhorst R, et al. Nasal absorption of propranolol in humans. Journal of Pharmaceutical Sciences 69: 1240, 1980

    Article  PubMed  CAS  Google Scholar 

  • Hussain AA, Hirai S, Bawarshi R. Nasal absorption of natural contraceptive steroids in rats. Progesterone absorption. Journal of Pharmaceutical Sciences 70: 466–467, 1981

    Article  PubMed  CAS  Google Scholar 

  • Ikegami M, Agata Y, Elkady T, Hallman M, Berry D, et al. Comparison of four surfactants: in vitro surface properties and responses of preterm lambs to treatment at birth. Pediatrics 79: 38–46, 1987

    PubMed  CAS  Google Scholar 

  • Kurose H, Seino Y, Shima M, Tanaka H, Ishida M, et al. Intranasal absorption of salmon calcitonin. Calcified Tissue International 41: 249–251, 1987

    Article  PubMed  CAS  Google Scholar 

  • Larsen C, Niebuhr Jorensen M, Tommerup B, Mygind N, Dagrosa EE, et al. Influence of experimental rhinitis on the gonadotropin response to intranasal administration of buserelin. European Journal of Clinical Pharmacology 33: 155–159, 1987

    Article  PubMed  CAS  Google Scholar 

  • Lee VHL. Enzymatic barriers to peptide and protein absorption and the use of penetration enhancers to modify absorption. In Davis et al. (Eds) Delivery systems for peptide drugs, pp. 87–104, Plenum Press, New York, 1986

    Google Scholar 

  • Longenecker JP. Nazlin R-Transnasal systemic delivery of insulin. In Davis et al. (Eds) Delivery systems for peptide drugs, pp. 211–220, Plenum Press, New York, 1986

    Google Scholar 

  • Moses AC, Flier JS. Unconventional routes of insulin administration. In Alberti & Krall (Eds) The diabetes annual/3, pp. 107–120, Elsevier Science, Amsterdam, 1987

    Google Scholar 

  • Moses AC, Gordon GS, Carey MC, Flier JS. Insulin administered intranasally as an insulin-bile salt aerosol. Effectiveness and reproducibility in normal and diabetic subjects. Diabetes 32: 1040–1047, 1983

    Article  PubMed  CAS  Google Scholar 

  • Mygind N. Nasal allergy, Blackwell Scientific Publications, Oxford, 1979

    Google Scholar 

  • Olanoff LS, Titus CR, Shea MS, Gison RE, Brooks CD. Effect of intranasal histamine on nasal mucosal blood flow and the antidiuretic activity of desmopressin. Journal of Clinical Investigation 80: 890–895, 1987

    Article  PubMed  CAS  Google Scholar 

  • Paquot N, Scheen AJ, Franchimont P, Lefevre PJ. The intranasal administration of insulin induces significant hypoglycaemia and classical counterregulatory hormonal responses in normal man. Diabète et Métabolisme 14: 31–36, 1988

    PubMed  CAS  Google Scholar 

  • Parr GD. Nasal delivery of drugs. Pharmacy International 4: 202–205, 1983

    Google Scholar 

  • Pintor C, Cella SG, Corda R, Locatelli V, Puggioni R, et al. Clonidine accelerates growth in children with impaired growth hormone secretion. Lancet 1: 1482–1484, 1985

    Article  PubMed  CAS  Google Scholar 

  • Pontiroli AE, Alberetto M, Calderara A, Pajetta E, Pozza G. Nasal administration of glucagon and human calcitonin in healthy subjects: a comparison of powders and spray solutions and of different enhancers. European Journal of Clinical Pharmacology, in press, 1989a

    Google Scholar 

  • Pontiroli AE, Alberetto M, Pajetta E, Calderara A, Pozza G. Human insulin plus sodium glycocholate in a nasal spray formulation: improved bioavailability and effectiveness in normal subjects. Diabète et Métabolisme 13: 441–443, 1987

    PubMed  CAS  Google Scholar 

  • Pontiroli AE, Alberetto M, Pozza G. Intranasal glucagon raises blood glucose concentrations in healthy volunteers. British Medical Journal 2: 462–463, 1983

    Article  Google Scholar 

  • Pontiroli AE, Alberetto M, Pozza G. Metabolic effects of intranasally administered glucagon: comparison with intramuscular and intravenous injection. Acta Diabetologica Latina 22: 103–110, 1985a

    Article  PubMed  CAS  Google Scholar 

  • Pontiroli AE, Alberetto M, Pozza G. Intranasal calcitonin and plasma calcium concentrations in normal subjects. British Medical Journal 1: 1390–1391, 1985b

    Article  Google Scholar 

  • Pontiroli AE, Alberetto M, Secchi A, Dossi G, Bosi I, et al. Insulin given intranasally induces hypoglycaemia in normal and diabetic subjects. British Medical Journal 1: 303–306, 1982

    Article  Google Scholar 

  • Pontiroli AE, Perfetti MG, Fattor B, Pozza G. Effect of intranasal growth hormone releasing hormone and corticotropin-releasing hormone administration on growth hormone and cortisol release: improved bioavailability by means of sodium-glycocholate. Journal of Clinical Endocrinology and Metabolism 68: 821–824, 1989b

    Article  PubMed  CAS  Google Scholar 

  • Pontiroli AE, Secchi A, Alberetto M. Alternative routes of peptide hormone administration. Special Topics in Endocrinology and Metabolism 7: 77–99, 1985c

    PubMed  CAS  Google Scholar 

  • Reginster JY, Denis D, Albert A, Franchimont P. Assessment of the biological effectiveness of nasal synthetic salmon calcitonin (SSCT) by comparison with intramuscular (i.m.) or placebo injection in normal subjects. Bone and Mineral 2: 133–140, 1987

    PubMed  CAS  Google Scholar 

  • Salzman R, Manson JE, Griffing GT, Kimmerle R, Ruderman N, et al. Intranasal aerosolized insulin. Mixed-meal studies and long-term use in type I diabetes. New England Journal of Medicine 312: 1078–1084, 1985

    Article  PubMed  CAS  Google Scholar 

  • Shibahara S, Morimoto Y, Notake M. Isolation and sequence analysis of the human corticotropin-releasing factor precursor gene. EMBO Journal 2: 775–779, 1983

    PubMed  CAS  Google Scholar 

  • Shionoiri H, Kaneko Y. Intranasal administration of alphanatriuretic peptide produces a prolonged diuresis in healthy man. Life Science 38: 773–778, 1986

    Article  CAS  Google Scholar 

  • Steege JF, Rupp SL, Stout AL, Bernhisel M. Bioavailability of nasally administered progesterone. Fertility and Sterility 46: 727–729, 1986

    PubMed  CAS  Google Scholar 

  • Treanor JJ, Betts RF, Erb SM, Roth FK, Dolin R. Intranasally administered interferon as prophylaxis against experimentally induced influenza A virus infection in humans. Journal of Infectious Diseases 156: 379–383, 1987

    Article  PubMed  CAS  Google Scholar 

  • Vance ML, Evans WS, Kaiser DL, Burke RL, Rivier J, et al. The effect of intravenous, subcutaneous, and intranasal GH-RH analog, [Nle27]GHRH(l–29)-NH2, on growth hormone secretion in normal men: dose-response relationship. Clinical Pharmacology and Therapeutics 40: 627–633, 1986

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Istituto Scientifico San Raffaele, Cattedra di Clinica Medica, Università di Milano, Milano, Italy

    Antonio E. Pontiroli, Anna Calderara & Guido Pozza

Authors
  1. Antonio E. Pontiroli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anna Calderara
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Guido Pozza
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pontiroli, A.E., Calderara, A. & Pozza, G. Intranasal Drug Delivery. Clin-Pharmacokinet 17, 299–307 (1989). https://doi.org/10.2165/00003088-198917050-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-198917050-00001

Keywords

Search

Navigation